๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b

โœ Scribed by Norbert Niederle; Otto Kloke; Dieter May; Reinhard Becher; Rainhardt Osieka; Carl Gottfried Schmidt

Publisher
Springer US
Year
1987
Tongue
English
Weight
422 KB
Volume
5
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interferon alfa-2b in the treatment of c
Interferon alfa-2b in the treatment of chronic granulocytic leukemia
โœ Daniel E. Bergsagel; Rainer H. Haas; Hans A. Messner ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 561 KB

Studies of the effect of interferon on the growth of colonies of myeloid leukemic blasts, myeloma colony-forming cells and normal hemopoietic precursor cells have shown that interferon does not specifically inhibit the growth of the malignant cells in culture, i.e. the growth of the malignant and th

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b
โœ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis